SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Alberu, J.
(Autor externo)

Obras con ISBN:0
Documentos en revistas:65
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- Sub-classification of borderline changes into diffuse or focal and its impact on long-term renal transplant outcomes (2022)
 
2.- Incidence of cervical intraepithelial lesions and human papilloma virus infection in female renal transplant recipients (2021)
 
3.- A urine score for noninvasive accurate diagnosis and prediction of kidney transplant rejection (2020)
 
4.- Intellectual performance of kidney transplant recipients' offspring: a cross-sectional, multicenter study (2019)
 
5.- First kidney domino transplant in Mexico (2019)
 
6.- Pretransplant angiotensin II type 1-receptor antibodies point to an increase in renal graft sub-intimal fibrosis in living- donor kidney transplant recipients (2019)
 
7.- Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years (2019)
 
8.- Report on the first kidney transplant chain in Mexico (2019)
 
9.- Treatment strategies and outcome of parvovirus B19 infection in kidney transplant recipients: A case series and literature review of 128 patients (2019)
 
10.- Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies (2018)
 
11.- Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial (2018)
 
12.- Value of C3d assay and IgG subclass in the prediction of the flow cytometry cross-match result for renal transplantation (2018)
 
13.- Anti-HLA-DQ antibodies are highly and independently related to the C1q-binding capacity of HLA antibodies (2017)
 
14.- Serum Inflammatory Biomarkers in Kidney Transplant Recipients and Renal Donors. (2016)
 
15.- Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies (2016)
 
16.- Tacrolimus trough levels as a risk factor for acute rejection in renal transplant patients (2016)
 
17.- Facing the metabolic syndrome epidemic in living kidney donor programs (2016)
 
18.- Influenza Immunization and the Generation of Anti-HLA and Anti-MICA Antibodies in Patients with Renal Failure and in Kidney Transplant Recipients (2016)
 
19.- Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era (2016)
 
20.- Neurocognitive Profile of Children Born to Kidney Transplant Recipients Mothers (2015)
 
21.- Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period? (2014)
 
22.- Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation (2013)
 
23.- Seroprevalence of Trypanosoma cruzi in kidney transplant donors and recipients in Mexico City (2013)
 
24.- Factores de riesgo para el desarrollo de función retardada del injerto en receptores de trasplante renal de donante fallecido y su impacto en la supervivencia de paciente e injerto (2013)
 
25.- Probability of deceased donor kidney transplantation based on % PRA (2013)
 
26.- Pre-nephrectomy angiotensin II type 1 receptor antibodies in living kidney donors: A concern? (2013)
 
27.- Pre-transplant angiotensin II type 1 receptor antibodies: A risk factor for decreased kidney graft function in the early post-transplant period? (2013)
 
28.- Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16(INK4 alpha) senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A (2012)
 
29.- CYP3A5 Polymorphism in Mexican Renal Transplant Recipients and its Association with Tacrolimus Dosing (2012)
 
30.- Intimidación a científicos en el área de trasplante renal (2012)
 
31.- A Comparative Study of the Traditional Method, and a Point-Score System for Allocation of Deceased-Donor Kidneys: A National Multicenter Study in Mexico (2011)
 
32.- Association of the Metabolic Syndrome and Long-Term Renal Function in Kidney Donors (2011)
 
33.- National Survey Carried Out by the Mexican Society of Transplantation in 2009 Regarding Deceased-Donor Kidney Allocation (2010)
 
34.- High Levels of IDO-Expressing CD16+ Peripheral Cells, and Tregs in Graft Biopsies From Kidney Transplant Recipients Under Belatacept Treatment (2010)
 
35.- Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: Implications for function outcome (2010)
 
36.- Risk Factors for Banff Borderline Acute Rejection in Protocol Biopsies and Effect on Renal Graft Function (2010)
 
37.- Risk Factors for Urinary Tract Infections During the First Year After Kidney Transplantation (2010)
 
38.- Comparison of Dissolution Properties of 2 Enteric-Coated Formulations Containing Mycophenolate Sodium: Myfortic vs Femulan (2010)
 
39.- Is a calcineurin inhibitor required as part of the immunosuppression scheme in kidney transplant recipients that share 2-haplotypes with their donors? [¿Es necesario un inhibidor de calcineurina como parte del esquema de inmunosupresión en (2010)
 
40.- Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination (2009)
 
41.- Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City. (2009)
 
42.- Polyoma virus in transplant recipients [Virus polioma en trasplante renal] (2008)
 
43.- HLA and MICA antibodies: further evidence of their impact on graft loss two years after their detection. (2006)
 
44.- An interesting case. (2006)
 
45.- Screening for tuberculosis in the study of the living renal donor in a developing country (2006)
 
46.- Markers of inflammation before and after renal transplantation (2005)
 
47.- Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy (2004)
 
48.- In vivo IL-10 and TGF-ß production by PBMC from long-term kidney transplant recipients with excellent graft function: A possible feedback mechanism participating in immunological stability (2004)
 
49.- Trasplante renal de esposo a esposa en cinco mujeres multíparas. ¿Efecto sensibilizante o efecto "tolerogénico" de la gestación? (2004)
 
50.- Effectiveness of preemptive therapy with gancyclovir in renal transplant recipients with high risk for cytomegalovirus disease (R-/D+) (2002)
 
51.- Genetic factors play an important role in the pathogenesis of hyperlipidemia post-transplantation (2002)
 
52.- Renal graft survival in systemic lupus erythematosus patients (2002)
 
53.- Asymptomatic gallstones and duration of cyclosporine use in kidney transplant recipients (2001)
 
54.- Effect of cyclosporine withdrawal on IL-10 production in kidney transplant recipients (2001)
 
55.- Serum erythropoietin levels in kidney donors after renal transplantation (2000)
 
56.- Withdrawal versus continuous cyclosporine therapy in kidney transplant recipients of one-haplotype-matched donors (1999)
 
57.- Leiomyosarcoma associated with Epstein-Barr virus in an adult with renal transplant [Leiomiosarcoma asociado con el virus de Epstein-Barr en un adulto con trasplante renal] (1998)
 
58.- Clinical and pathological characterization of posttransplantation lymphoproliferative disorders in kidney transplant recipients: Single institution experience (1996)
 
59.- Cutaneous neoplasms and human papillomavirus in renal transplant patients: Experience of one center in Mexico (1996)
 
60.- Acute abdomen requiring emergency surgery in renal allograft recipients during a single center cohort follow-up (1996)
 
61.- Posttransplant perirenal collections: Clinical significance (1996)
 
62.- Prevalence of hepatitis B and C in patients registered on the cadaver kidney transplant waiting list in Mexico (1996)
 
63.- Prevalence of hepatitis C virus in a group of kidney transplant patients in Mexico (1992)
 
64.- Congenital dilatations of the biliary tree. (1978)
 
65.- Meso-renal derivation. A surgical alternative in the treatment of portal hypertension [Derivación meso-renal. Una alternativa quirúrgica en el tratamiento de la hipertensión portal.] (1978)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.